Syndax Pharmaceuticals Inc
NASDAQ:SNDX
| Market Cap (Intraday) | 1.04B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $23.03 |
| 50-Day MA | $22.69 |
| 200-Day MA | $19.48 |
Syndax Pharmaceuticals, Inc. Stock, NASDAQ:SNDX
35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.419.1400
Number of Employees: 35
Description
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.